e-Drug3D

104

CHLOROTRIANISENE

DISCONTINUED


INN
CHLOROTRIANISENE

cas 569-57-3
CLASS

GENITO
ANTINEOPLASTIC AGENTS
ESTROGENIC

ROUTE (list)

ORAL

ATC code

G03CA06

PK parameters

Target

-

DrugCentral

Estrogen receptor beta UNIPROT Q92731 ESR2

Download SDF file 1-[2-chloro-1,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene

Formula:
C23H21ClO3

Calculated chemical properties:

MW 380.85
NB_atoms 27
XLogP 5.87
PSA 33.364
NB_HD 0
NB_HA 3
fsp3 0.13
Lipinski(0=no;1=yes) 0

FDA
NDA 008102 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 011444 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 016235 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 084652 (pdf not found) INN (CHLOROTRIANISENE) CHLOROTRIANISENE (BANNER PHARMACAPS) APPROVAL= - YEAR= 0 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL